$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Excitotoxicity is the leading cause of neuronal death in brain ischemia and a contributing factor in multiple neurodegenerative diseases1,2,3,4,5,6,7,8,9. Disruption of oxygenated blood flow to the brain (e.g., due to a blood clot) results in the malfunction of glutamate transporters, leading to accumulation of glutamate in the synapse. This excess of glutamate over-activates post-synaptic Glutamate Receptors (GluRs) leading to an excessive (catalytic, non-stoichiometric) influx of Ca2+ into neurons (Figure 1A). This detrimental influx leads to progressive postsynaptic neurodegeneration that morphologically and mechanistically ranges from apoptosis to regulated necrosis10,11,12. Although they were based on successful interventions in animal models, multiple clinical trials of GluR antagonists that sought to block Ca2+ entry and promote cell viability have failed in the clinical setting13,14,15,16. A likely critical contributor to these failures is the fact that (in contrast to the animal models) treatment in the clinical setting is administered hours after stroke onset, causing the intervention to block late-acting neuroprotective mechanisms, while failing to interrupt degenerative signaling downstream of GluRs14,16,17. An alternative approach, which is based on thrombolysis, can only be administered within a severely restricted time window, leaving many patients (who suffer stroke at home with poorly identifiable time of onset) unable to benefit from it17. These setbacks emphasize the need to focus excitotoxicity research on the study of events occurring after GluR hyper-stimulation and differentiate subsequent degenerative cascades from concurrent neuroprotective processes. This approach can help prevent cell damage and identify efficient drug targets that can be administered later after damage onset.
One approach to identify subsequent events in excitotoxicity is to study the cell-death signaling mechanisms downstream of GluR hyperstimulation, such as those leading to mitochondrial collapse. Drastic malfunction of mitochondrial physiology and dynamics is a hallmark of neurodegeneration, as seen in excitotoxicity18,19,20. While all cells depend on mitochondrial function and availability for survival, activity, and cellular maintenance, neurons are particularly dependent on mitochondrial energy production to support signal transmission and propagation. Specifically, neurons spend ~50% of their signaling-related energy consumption to restore resting membrane potential following the activation of postsynaptic receptors/channels21, with high dependence on oxygen and glucose. The reduced availability of glucose and oxygen observed in stroke leads to serious mitochondrial alterations, causing further reduction in ATP production19,22,23,24. However, studies to identify the sequence of events that lead to mitochondrial collapse produced controversial results and lacked consensus. Analyzing mitochondrial morphology can help understand these events leading to mitochondrial pathology since it is a good indicator of neuronal health25,26,27,28,29. Filamentous mitochondria are representative of a healthy neuron, whereas fragmented mitochondria reveal substantial neuronal damage that could lead to cell death. Analyzing mitochondrial morphology in live animals under different genetic conditions can help focus on specific genes and pathways involved in mitochondrial-dependent neurodegeneration in excitotoxicity.
Another approach to identifying subsequent events that might regulate the extent of excitotoxic neurodegeneration is to study the transcriptional neuroprotective mechanisms that mitigate some of the effects of excitotoxicity14,16. However, the lack of specificity of key neuroprotective transcription factors and the divergence of experimental setups impede the success of efforts to clearly identify core neuroprotective programs (especially in regulated necrosis).
Therefore, both the study of downstream death signaling pathways and the study of transcriptional neuroprotection in excitotoxicity encountered great difficulties and disagreements on observed outcomes. Much of this controversy is likely to arise from the use of ex vivo or in vitro models of excitotoxicity, and the variability introduced by the specificity of different experimental setups. It is therefore highly beneficial to focus on identifying core mechanisms that are highly conserved, and study them in vivo. The simple model system of the nematode C. elegans offers a particularly effective option, due to the potent combination of particularly powerful and diversified research tools, the conservation of core cell-death pathways, and the rich information on the structure and connectivity of its nervous system30,31,32,33. Indeed, the seminal work of the Driscoll lab on the genetic analysis of necrotic neurodegeneration in mechanosensory neurons is an excellent demonstration of the power of this approach34. Importantly for the analysis of excitotoxicity, the conservation of signaling pathways in the nematode includes all major components of glutamatergic neurotransmission35,36.
The nematode excitotoxicity model builds on these seminal studies, allowing the researcher to study biochemical processes akin to those that occur in stroke and other neurodegenerative diseases affected by glutamate-dependent neurotoxicity. To induce excitotoxic conditions in C. elegans this experimental approach uses an excitotoxicity strain that is the combination of a knockout of a glutamate transporter gene (glt-3) and neuronal sensitizing genetic background (nuls5 [Pglr-1::GαS(Q227L)]) to produce GluR hyperstimulation and neurodegeneration37. This excitotoxicity strain exposes 30 specific (glr-1-expressing) neurons that are postsynaptic to glutamatergic connections to excitotoxic neurodegeneration. Of these 30 at-risk neurons, individual neurons go through necrosis as the animal progresses through development (with mixed stochasticity and partial preference towards certain specific neurons38), while at the same time cell corpses are also being gradually removed. In combination with the accessibility of many mutant strains, this approach allows the study of multiple pathways that affect neurodegeneration and neuroprotection. These approaches have already been used to analyze some of the downstream death signaling cascades39 and transcriptional regulators of excitotoxic neurodegeneration in excitotoxicity38,40. Like other cases of necrotic neurodegeneration in the worm41, the nematode's excitotoxic neurodegeneration does not involve classic apoptosis40.
This methods paper describes the basic system to induce, quantify, and manipulate excitotoxic necrotic neurodegeneration in C. elegans. Furthermore, it outlines two main protocols that are currently in use to streamline studies of specific aspects of nematode excitotoxicity. By using fluorescent reporters and live in vivo imaging the researcher can study mitochondrial involvement and dynamics in the nematode model of excitotoxic neurodegeneration. To determine the effect of specific neuroprotective transcription factors, the investigator can use cell type-specific expression of fluorescent markers, dissociation of animals into single cells, and FACS to isolate specific neurons that are at risk of necrosis from excitotoxicity. These cell-type specific isolated neurons can then be used for RNA sequencing in strains that harbor mutations in key transcription factors. Put together, these methods can allow researchers to tease out the molecular underpinnings of excitotoxic neurodegeneration and neuroprotection in vivo with great clarity and precision.